Literature DB >> 20191520

Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland.

Ariane L Herrick1, Holly Ennis, Monica Bhushan, Alan J Silman, Eileen M Baildam.   

Abstract

OBJECTIVE: Childhood scleroderma encompasses a rare, poorly understood spectrum of conditions. Our aim was to ascertain the incidence of childhood scleroderma in its different forms in the UK and Ireland, and to describe the age, sex, and ethnicity of the cases.
METHODS: The members of 5 specialist medical associations including pediatricians, dermatologists, and rheumatologists were asked to report all cases of abnormal skin thickening suspected to be localized (including linear) scleroderma or systemic sclerosis (SSc) in children <16 years of age first seen between July 2005 and July 2007.
RESULTS: We received notification of 185 potential cases, and 94 valid cases were confirmed: 87 (93%) with localized scleroderma and 7 (7%) with SSc. This gave an incidence rate per million children per year of 3.4 (95% confidence interval [95% CI] 2.7-4.1) for localized scleroderma, including an incidence rate of 2.5 (95% CI 1.8-3.1) for linear scleroderma, and 0.27 (95% CI 0.1-0.5) for SSc. Of the 87 localized cases, 62 (71%) had linear disease. Of localized disease cases, 55 (63%) were female, 71 (82%) were classified as white British, and the patients' mean age when first seen in secondary care was 10.4 years. Of the 7 SSc cases, all were female, 6 (86%) were white British, and the mean age when first seen was 12.1 years. The median delay between onset and being first seen was 13.1 months for localized scleroderma and 7.2 months for SSc.
CONCLUSION: These data provide additional estimates of the incidence of this rare disorder and its subforms.

Entities:  

Mesh:

Year:  2010        PMID: 20191520     DOI: 10.1002/acr.20070

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  28 in total

Review 1.  Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.

Authors:  Caterina Ferreli; Giulia Gasparini; Aurora Parodi; Emanuele Cozzani; Franco Rongioletti; Laura Atzori
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 2.  A Practical Approach to Juvenile Dermatomyositis and Juvenile Scleroderma.

Authors:  Liza J McCann; Clare E Pain
Journal:  Indian J Pediatr       Date:  2016-02       Impact factor: 1.967

3.  Musculoskeletal MRI findings of juvenile localized scleroderma.

Authors:  Eric P Eutsler; Daniel B Horton; Monica Epelman; Terri Finkel; Lauren W Averill
Journal:  Pediatr Radiol       Date:  2017-01-14

4.  French recommendations for the management of systemic sclerosis.

Authors:  Eric Hachulla; Christian Agard; Yannick Allanore; Jerome Avouac; Brigitte Bader-Meunier; Alexandre Belot; Alice Berezne; Anne-Sophie Bouthors; Geraldine Condette-Wojtasik; Joël Constans; Pascal De Groote; Elisabeth Diot; Florence Dumas; Patrick Jego; Francisca Joly; David Launay; Veronique Le Guern; Janine-Sophie Le Quintrec; Geraldine Lescaille; Christophe Meune; Bruno Moulin; Christelle Nguyen; Nadine Omeish; Frederic Pene; Marie-Aleth Richard; Juliette Rochefort; Alexandra Roren; Olivier Sitbon; Vincent Sobanski; Marie-Elise Truchetet; Luc Mouthon
Journal:  Orphanet J Rare Dis       Date:  2021-07-26       Impact factor: 4.123

5.  [Localized scleroderma (morphea) in childhood].

Authors:  L Weibel
Journal:  Hautarzt       Date:  2012-02       Impact factor: 0.751

6.  Autoimmune Diseases in Patients With Cutaneous Lupus Erythematosus.

Authors:  Elaine Kunzler; Linda S Hynan; Benjamin F Chong
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

Review 7.  The central nervous system manifestations of localized craniofacial scleroderma: a study of 10 cases and literature review.

Authors:  Ezekiel Maloney; Sarah J Menashe; Ramesh S Iyer; Sarah Ringold; Amit K Chakraborty; Gisele E Ishak
Journal:  Pediatr Radiol       Date:  2018-07-03

Review 8.  Development of minimum standards of care for juvenile localized scleroderma.

Authors:  Tamás Constantin; Ivan Foeldvari; Clare E Pain; Annamária Pálinkás; Peter Höger; Monika Moll; Dana Nemkova; Lisa Weibel; Melinda Laczkovszki; Philip Clements; Kathryn S Torok
Journal:  Eur J Pediatr       Date:  2018-05-04       Impact factor: 3.183

Review 9.  Update on juvenile systemic sclerosis.

Authors:  Ivan Foeldvari
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

Review 10.  Treatment of early diffuse systemic sclerosis skin disease.

Authors:  Tracy M Frech; Victoria K Shanmugam; Ami A Shah; Shervin Assassi; Jessica K Gordon; Faye N Hant; Monique E Hinchcliff; Virginia Steen; Dinesh Khanna; Cristiane Kayser; Robyn T Domsic
Journal:  Clin Exp Rheumatol       Date:  2013-07-23       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.